Biogen (BIIB) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.25 | 1.09 | 1.04 | 0.64 | 2.42 | 2.45 | |||
Changes by years, y/y, % | -28% | +331% | -4% | -38% | +278% | +47.2% |
Biogen. Debt/EBITDA
Biogen. Debt/EBITDA, changes, %
Biogen (BIIB) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Debt/EBITDA | 0.51 | 0.18 | 2.50 | 2.76 | 2.45 | 2.45 | ||
Changes by years, y/y, % | -68% | -78% | +446% | +423% | +385% | |||
Changes by quarters, q/q, % | -4% | -64% | +1 256% | +10% | -11% |